General Information

Product

Parkin Antibody Affinity Purified

Verified Applications

ELISA, WB

Host

Rabbit

Species Cross Reactivity

Human

Immunogen

Synthetic peptide taken within amino acid region 390-440 on human Parkin protein.

Accession #

GenBank: BAA25751.1

Physical Properties

Quantity

100 µg

Volume

200 µl

Concentration

0.55.75 µg/µl in antibody stabilization buffer

Form

Affinity Purified

Clonality

Polyclonal

Storage

-20⁰C for long term storage

Application Protocol

DB

1:10,000

ELISA

1:10,000

Western Blot

1:500

Protein

Uniprot #

O60260

Overview

Acts within a multiprotein E3 ubiquitin ligase complex, by catalyzing the covalent attachment of ubiquitin moieties onto substrate proteins. It also participates in the removal and/or detoxification of proteins that are abnormally folded or damaged.

Molecular Function

Ligase, Chaperone binding, Protein kinase binding

Subcellular Location

Cytoplasm, Nucleus, Endoplasmic reticulum, Mitochondrion

Expression

Expressed highly in the brain, and is also expressed in the heart, testis and skeletal muscle. Expression is down-regulated or absent in tumor biopsies and in the brain of PARK2 patients.

Structure

Forms E3 ubiquitin ligase complex with UBE2L3 or UBE2L6. Binds to C2A and C2B domains of SYTqq and interacts and regulates the turnovers of SEPT5.

Alternative Nomenclature

AR JP antibody

E3 ubiquitin ligase antibody

FRA6E antibody

LPRS 2 antibody

PARK 2 antibody

Parkin 2 antibody

Parkinson disease (autosomal recessive juvenile) 2 antibody

Parkinson protein 2, E3 ubiquitin protein ligase (parkin) antibody

PDJ antibody

PRKN 2 antibody

Ubiquitin E3 ligase PRKN antibody